Long-Chain Fatty Acid Oxidation Disorders In-Clinic Disease Monitoring Program ClinicalTrials.gov ID NCT04632953 Sponsor Ultragenyx Pharmaceutical Inc Information provided by Ultragenyx Pharmaceutical Inc (Responsible Party) Last Update Posted 2024-08-29 Study Overview The primary objective of this...
In a study published in Aging Cell, Gebru et al describe the molecular and circadian profile of aged FKBP51 KO mice. Their finding shed light on the mechanisms that provide enhanced stress resilience in the model and provides additional evidence towards the benefits of lowering FKBP51, which their...
Sanofi Genzyme Rare Disease Registry - A Multi-Center, International, Longitudinal, Observational program designed to track natural history and outcomes of patients with Gaucher, Fabry, MPSI, and Pompe Disease ( Gaucher registry, Fabry registry, MPSI registry, Pompe registry) International...
Dr. Laura Blair was among 27 USF Faculty members to be recognized with an Outstanding Research Achievement Award this year. She received this award for distinguished contributions to the field of neuroscience, particularly for elucidating the role of discrete molecular chaperones in the brain in the...